Lenalidomide 5mg capsules
NHS hospitals in England used £106,170,131 of indicative cost of Lenalidomide 5mg capsules in the 12 months to April 2026, about 0.4% of all hospital medicines spend. That is up 16.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenalidomide 5mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenalidomide 5mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £4,222,290 |
| University Hpls Of Leicester Nhs Trust | £3,565,070 |
| Derby Teaching Hospitals Nhs Found Trust | £2,506,480 |
| United Lincolnshire Hospitals Nhs Trust | £2,022,320 |
| University Hpls North Midlands Nhs Trust | £1,984,240 |
| South Tees Hosp Nhs Foundation Trust | £1,974,380 |
| Western Sussex Hospitals Nhs Found Trust | £1,858,270 |
| Sheffield Teaching Hospitals Nhs Trust | £1,854,020 |
| Oxford University Hospitals Nhs Ft | £1,818,660 |
| Chesterfield Royal Hospital Nhs F/T | £1,694,560 |
The primary-care picture
Lenalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenalidomide medicine page.